Cargando…
Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
More than 20 years after the identification of the hepatitis C virus (HCV) as a novel human pathogen, the only approved treatment remains a combination of pegylated interferon-α and ribavirin. This rather non-specific therapy is associated with severe side effects and by far not everyone benefits fr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185568/ https://www.ncbi.nlm.nih.gov/pubmed/21994615 http://dx.doi.org/10.3390/v2102169 |